You are here

Pfizer

First FDA-Approved RSV Vaccines Expected Later This Year: The Top Vaccines And Their Effectiveness

First FDA-Approved RSV Vaccines Expected Later This Year: The Top Vaccines And Their Effectiveness

Forbes

Moderna Therapeutics

Flag link:

Pfizer, Valneva remove half of participants from study of Lyme disease shot

Pfizer, Valneva remove half of participants from study of Lyme disease shot

BioPharma Dive

clinical trials

Flag link:

ASCO GU: Pfizer touts Talzenna's strong showing in PARP prostate cancer battle with AstraZeneca, J&J

ASCO GU: Pfizer touts Talzenna's strong showing in PARP prostate cancer battle with AstraZeneca, J&J

Fierce Pharma

prostate cancer

Flag link:

Pfizer cites positive results on nasal spray migraine treatment

Pfizer cites positive results on nasal spray migraine treatment

Medical Xpress

Flag link:

US government, Pfizer and others side with Sanofi and Regeneron in Supreme Court patent case

US government, Pfizer and others side with Sanofi and Regeneron in Supreme Court patent case

Endpoints

Flag link:

Pfizer begins plan to challenge Shingrix with an mRNA vaccine

Pfizer begins plan to challenge Shingrix with an mRNA vaccine

BioPharma Dive

Flag link:

Biohaven looks to seize a new opportunity

Biohaven looks to seize a new opportunity

EP Vantage

taldefgrobep alfa

Flag link:

Pfizer ordered to disclose FBI communications in trade secrets case

Pfizer ordered to disclose FBI communications in trade secrets case

Endpoints

Regor Therapeutics

Flag link:

This Week at FDA: Restructuring at inspections office, new guidances and staff, and more

This Week at FDA: Restructuring at inspections office, new guidances and staff, and more

RAPS.org

regulatory inspections

Flag link:

mRNA vaccines: Four major clinical trial readouts to watch in 2023

mRNA vaccines: Four major clinical trial readouts to watch in 2023

Clinical Trials Arena

clinical trials

Moderna Therapeutics

Flag link:

FDA to convene advisers on review of RSV vaccines from GSK, Pfizer

FDA to convene advisers on review of RSV vaccines from GSK, Pfizer

BioPharma Dive

Flag link:

In mysterious FDA approval, Pfizer quietly wins Ibrance breast cancer expansion

In mysterious FDA approval, Pfizer quietly wins Ibrance breast cancer expansion

Fierce Pharma

Flag link:

Pfizer’s full-year revenues grow 23%, top $100B

Pfizer’s full-year revenues grow 23%, top $100B

Medical Marketing and Media

Flag link:

Pharma reputation drops to pre-pandemic normal, with Pfizer and Moderna falling in the ranks

Pharma reputation drops to pre-pandemic normal, with Pfizer and Moderna falling in the ranks

Medical Marketing and Media

Moderna Therapeutics

Flag link:

Pfizer-backed decentralized cooperative raises $4.1M to fund longevity research

Pfizer-backed decentralized cooperative raises $4.1M to fund longevity research

Endpoints

Flag link:

FDA reports initial 'no signal' for stroke risk with Pfizer boosters, launches concomitant flu shot study

FDA reports initial 'no signal' for stroke risk with Pfizer boosters, launches concomitant flu shot study

Endpoints

bivalent boosters

Flag link:

mRNA Covid Shots Safe And Effective In Children Ages 5-11, Large Study Finds—Though Vaccine Uptake Remains Low

mRNA Covid Shots Safe And Effective In Children Ages 5-11, Large Study Finds—Though Vaccine Uptake Remains Low

Forbes

Moderna Therapeutics

Flag link:

Roivant’s Matt Gline on the hub-and-spoke biotech model and lessons learned from Axovant

Roivant’s Matt Gline on the hub-and-spoke biotech model and lessons learned from Axovant

Biopharma Dive

Roivant Sciences

Flag link:

AbbVie, Novartis and more win national coverage in China even as Pfizer's Paxlovid gets left out

AbbVie, Novartis and more win national coverage in China even as Pfizer's Paxlovid gets left out

Fierce Pharma

Flag link:

Pfizer inks deal to snatch Abzena's new North Carolina manufacturing site

Pfizer inks deal to snatch Abzena's new North Carolina manufacturing site

Endpoints

drug manufacturing

Flag link:

Pages